4.6 Letter

Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis

Maria Elena Flacco et al.

HEART (2020)

Article Public, Environmental & Occupational Health

Existing Data Sources in Clinical Epidemiology: The Danish COVID-19 Cohort

Anton Pottegard et al.

CLINICAL EPIDEMIOLOGY (2020)

Article Endocrinology & Metabolism

Outcomes of Patients With Hypothyroidism and COVID-19: A Retrospective Cohort Study

Maaike van Gerwen et al.

FRONTIERS IN ENDOCRINOLOGY (2020)

Article Physiology

The Role of Thyroid Hormone in the Innate and Adaptive Immune Response during Infection

Julia Rubingh et al.

COMPREHENSIVE PHYSIOLOGY (2020)

Article Endocrinology & Metabolism

Duration of over- and under-treatment of hypothyroidism is associated with increased cardiovascular risk

Mads Lillevang-Johansen et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)